Montelukast 10mg Tablet in PCD pharma franchise in Hyderabad

Montelukast 10mg Tablet in pharmaceutical manufacturing company in Mumbai

Montelukast 10mg Tablet in antiallergic pharma franchise in Pune

Montelukast 10mg Tablet in pharma suppliers in Delhi

Montelukast 10mg Tablet in pharma export companies in Kolkata
Montelukast 10mg Tablet in pharma franchise opportunities in Bengaluru

Home/Products /montelukast-10-mg-tablet

About the Product

Description


Montelukast 10 mg Tablet is a leukotriene receptor antagonist that works by blocking substances called leukotrienes, which cause inflammation, swelling, and constriction in the airways. This helps in improving breathing and controlling symptoms associated with allergic rhinitis and asthma. It is typically used as a preventive treatment and not for acute asthma attacks.

Generally well-tolerated. Possible side effects include headache, abdominal pain, dizziness, fatigue, and occasionally mood changes or sleep disturbances. Rare but serious effects may include allergic reactions or neuropsychiatric events.

Indicated for the prophylaxis and chronic treatment of asthma, the relief of symptoms of seasonal allergic rhinitis (hay fever), and exercise-induced bronchoconstriction in adults and adolescents.

This tablet is not intended for the treatment of acute asthma attacks. Patients should continue their other prescribed asthma medications unless advised otherwise. Always use under medical supervision and do not exceed the recommended dosage.

Store at room temperature (15-30°C), away from direct sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Montelukast 10 mg Tablets in the PCD pharma franchise market?

Montelukast Tablets have strong demand in the respiratory and allergy management segment, making them a widely prescribed product for pharma distributors, wholesalers, and franchise partners. It is commonly used for asthma, allergic rhinitis, seasonal allergies, and exercise-induced bronchospasm, ensuring consistent prescription-driven demand.

Why should medical distributors include Montelukast 10 mg Tablets in their product range?

Medical distributors and agencies benefit from the high and continuous demand in chronic respiratory and allergy care. Helps control asthma symptoms and prevent attacks Effective in seasonal and perennial allergic rhinitis Reduces airway inflammation triggered by allergens Widely prescribed by pulmonologists, ENT specialists, and general physicians Common in long-term maintenance therapy for asthma patients Strong demand in both urban and semi-urban markets This makes it a high-volume, fast-moving respiratory and allergy product.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Montelukast 10 mg Tablets with monopoly rights, promotional support, quality manufacturing standards, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and franchise partners benefit from consistent chronic prescription demand, strong respiratory and allergy season sales, repeat monthly usage in asthma patients, and stable year-round turnover in the respiratory segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and pharma franchise partners can contact Cafoli LifeCare Pvt Ltd to discuss monopoly territory rights, pricing structure, marketing support, and complete respiratory and allergy product portfolio access to build a strong presence in the asthma and ENT market.